Global Payments' (NYSE:GPN) five-year earnings growth trails the decent shareholder returns




  • In Business
  • 2022-05-30 17:26:37Z
  • By Simply Wall St.
 

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the market. But Global Payments Inc. (NYSE:GPN) has fallen short of that second goal, with a share price rise of 43% over five years, which is below the market return. The last year has been disappointing, with the stock price down 32% in that time.

Since the stock has added US$2.9b to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

See our latest analysis for Global Payments

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

During five years of share price growth, Global Payments achieved compound earnings per share (EPS) growth of 23% per year. This EPS growth is higher than the 7% average annual increase in the share price. Therefore, it seems the market has become relatively pessimistic about the company.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. This free interactive report on Global Payments' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

A Different Perspective

While the broader market lost about 10% in the twelve months, Global Payments shareholders did even worse, losing 31% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Longer term investors wouldn't be so upset, since they would have made 8%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 2 warning signs for Global Payments you should be aware of.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

COMMENTS

More Related News

Investing in XOMA (NASDAQ:XOMA) five years ago would have delivered you a 196% gain
Investing in XOMA (NASDAQ:XOMA) five years ago would have delivered you a 196% gain

While XOMA Corporation ( NASDAQ:XOMA ) shareholders are probably generally happy, the stock hasn't had particularly...

Y-mAbs Therapeutics (NASDAQ:YMAB) shareholders have endured a 57% loss from investing in the stock a year ago
Y-mAbs Therapeutics (NASDAQ:YMAB) shareholders have endured a 57% loss from investing in the stock a year ago

Y-mAbs Therapeutics, Inc. ( NASDAQ:YMAB ) shareholders should be happy to see the share price up 25% in the last month...

With EPS Growth And More, MS INTERNATIONAL (LON:MSI) Makes An Interesting Case
With EPS Growth And More, MS INTERNATIONAL (LON:MSI) Makes An Interesting Case

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Investors in Restore (LON:RST) have made a return of 14% over the past year
Investors in Restore (LON:RST) have made a return of 14% over the past year

Passive investing in index funds can generate returns that roughly match the overall market. But if you pick the right...

Sigma Healthcare (ASX:SIG) shareholders are up 19% this past week, but still in the red over the last five years
Sigma Healthcare (ASX:SIG) shareholders are up 19% this past week, but still in the red over the last five years

Sigma Healthcare Limited ( ASX:SIG ) shareholders should be happy to see the share price up 21% in the last month. But...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

  • arafi
    (2022-06-25 12:22:08Z)

    hard stock investment

    REPLY
  • fb账号解封
    (2022-06-29 06:13:59Z)

    事实上,facebook账户被屏蔽是正常的。特别是在美国大选的初期,该组织发布了许多信息,都在抱怨账户被屏蔽。如果您的个人数据是真实的,并且没有严重违反社区规定,那么解封并不困难

    REPLY

Top News: Business